TNF Pharmaceuticals/$QCLS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About TNF Pharmaceuticals
Q/C Technologies Inc is engaged in building blockchain infrastructure that is faster and more energy-efficient. The company uses laser-based processors inspired by quantum technology that can solve complex problems at the speed of light. By combining photonic computing with cryptocurrency systems, the company creates powerful and sustainable solutions for the next generation of blockchain applications.
Ticker
$QCLS
Sector
Primary listing
Employees
6
Headquarters
Website
QCLS Metrics
BasicAdvanced
$6.9M
-
-$159.52
2.28
-
Price and volume
Market cap
$6.9M
Beta
2.28
52-week high
$8.94
52-week low
$3.24
Average daily volume
2.9M
Financial strength
Current ratio
0.928
Quick ratio
0.687
Profitability
Management effectiveness
Return on assets (TTM)
-24.00%
Return on equity (TTM)
-115.40%
Valuation
Price to book
0.22
Price to tangible book (TTM)
-0.21
Price to free cash flow (TTM)
-0.028
Free cash flow yield (TTM)
-3,632.40%
Free cash flow per share (TTM)
-141.293
Growth
Earnings per share change (TTM)
-86.64%
3-year earnings per share growth (CAGR)
-50.30%
QCLS News
AllArticlesVideos
TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol “QCLS” to Reflect Strategic Focus on Quantum Class Photonic Computing
Business Wire3 weeks ago
TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
Business Wire4 weeks ago
TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Business Wire1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for TNF Pharmaceuticals stock?
TNF Pharmaceuticals (QCLS) has a market cap of $6.9M as of October 14, 2025.
What is the P/E ratio for TNF Pharmaceuticals stock?
The price to earnings (P/E) ratio for TNF Pharmaceuticals (QCLS) stock is 0 as of October 14, 2025.
Does TNF Pharmaceuticals stock pay dividends?
No, TNF Pharmaceuticals (QCLS) stock does not pay dividends to its shareholders as of October 14, 2025.
When is the next TNF Pharmaceuticals dividend payment date?
TNF Pharmaceuticals (QCLS) stock does not pay dividends to its shareholders.
What is the beta indicator for TNF Pharmaceuticals?
TNF Pharmaceuticals (QCLS) has a beta rating of 2.28. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.